LL-37 5 MG

LL-37 is a human cathelicidin-derived antimicrobial peptide. It is studied for its broad-spectrum activity against bacteria, viruses, and fungi, as well as its roles in immune modulation, wound repair, and inflammation balance.

BENEFITS

• Broad-spectrum defense — studied for antimicrobial activity against bacteria, viruses, and fungi.
• Immune modulation — explored for balancing innate and adaptive immune responses.
• Wound healing — linked to angiogenesis and tissue regeneration research.
• Anti-inflammatory — studied for calming excessive inflammatory signaling.
• Barrier protection — interest in skin, lung, and gut epithelial defense.

WHAT RESEARCHERS LOOK AT

• Mechanism: cationic peptide disrupting microbial membranes and signaling immune pathways.
• Role in epithelial defense of skin, lung, and gastrointestinal tract.
• Angiogenesis and wound-healing effects in tissue models.
• Exploration in sepsis, chronic infections, and autoimmune conditions.

QUICK SPECS

• Form: Lyophilized peptide
• Net per vial: 10 mg
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: 2–8 °C, protect from light

IDENTITY BASICS

• Sequence: LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
• Formula / M.W.: C215H358N64O46, ~4493 g/mol
• CAS: 221231-10-3

SELECTED RESEARCH

• PubChem entry — chemical identity:
  
  https://pubchem.ncbi.nlm.nih.gov/compound/16130166
  
• Antimicrobial and immune roles of LL-37:
  
  https://pubmed.ncbi.nlm.nih.gov/12794199/
  
• LL-37 in wound healing and angiogenesis:
  
  https://pubmed.ncbi.nlm.nih.gov/16489025/
  
• Role in lung and epithelial defense:
  
  https://pubmed.ncbi.nlm.nih.gov/17923416/
  
• LL-37 immune modulation overview:
  
  https://pubmed.ncbi.nlm.nih.gov/20193060/
  

DISCLAIMER

• This product is intended for laboratory research use only.

• Not for human or veterinary use.

• Not approved for diagnostic, therapeutic, or medical applications.

• Handle using appropriate laboratory safety procedures and personal protective equipment.